loadpatents
Patent applications and USPTO patent grants for Reddy; Rapolu Raji.The latest application filed is for "polymorphs of darunavir".
Patent | Date |
---|---|
Polymorphs of darunavir Grant 9,580,440 - Reddy , et al. February 28, 2 | 2017-02-28 |
Salts of raltegravir Grant 8,962,833 - Reddy , et al. February 24, 2 | 2015-02-24 |
Crystalline hydrochloride salt of darunavir Grant 8,853,430 - Reddy , et al. October 7, 2 | 2014-10-07 |
Polymorphs Of Darunavir App 20140200356 - Reddy; Bandi Parthasaradhi ;   et al. | 2014-07-17 |
Crystalline forms of maraviroc phosphate and process for maraviroc amorphous form Grant 8,779,143 - Reddy , et al. July 15, 2 | 2014-07-15 |
Polymorphs of raltegravir potassium Grant 8,742,105 - Reddy , et al. June 3, 2 | 2014-06-03 |
Hydrated form of erlotinib free base and a process for preparation of erlotinib hydrochloride polymorph form a substantially free of polymorph form B Grant 8,669,265 - Reddy , et al. March 11, 2 | 2014-03-11 |
Process For Nucleosides App 20140046062 - Reddy; Bandi Parthasaradhi ;   et al. | 2014-02-13 |
Process For Purification Of Aprepitant App 20130345418 - Reddy; Bandi Parthasaradhi ;   et al. | 2013-12-26 |
Novel Hydrated Form of Erlotinib Free Base and a Process For Preparation Of Erlotinib Hydrochloride Polymorph Form A Substantially Free of Polymorph Form B App 20130252978 - REDDY; BANDI PARTHASARADHI ;   et al. | 2013-09-26 |
Crystalline Forms Of Maraviroc Phosphate And Process For Maraviroc Amorphous Form App 20130211091 - Reddy; Bandi Parthasaradhi ;   et al. | 2013-08-15 |
Salts Of Lapatinib App 20130131090 - Reddy; Bandi Parthasaradhi ;   et al. | 2013-05-23 |
Polymorphs of sunitinib malate Grant 8,329,740 - Reddy , et al. December 11, 2 | 2012-12-11 |
Stereoselective synthesis of benzimidazole sulfoxides Grant 8,173,817 - Reddy , et al. May 8, 2 | 2012-05-08 |
Stereoselective synthesis of benzimidazole sulfoxides Grant 7,928,241 - Reddy , et al. April 19, 2 | 2011-04-19 |
Process of making sertraline form II Grant 7,772,437 - Reddy , et al. August 10, 2 | 2010-08-10 |
Process of making sertraline form I Grant 7,772,438 - Reddy , et al. August 10, 2 | 2010-08-10 |
Pharmaceutical Compositions Of Valdecoxib App 20090227645 - Reddy; Bandi Parthasaradhi ;   et al. | 2009-09-10 |
Process Of Making Sertraline Form Ii App 20090177009 - Reddy; Bandi Parthasaradhi ;   et al. | 2009-07-09 |
Process Of Making Sertraline Form I App 20090177010 - Reddy; Bandi Parthasaradhi ;   et al. | 2009-07-09 |
Polymorphs of tolterodine tartrate Grant 7,393,874 - Reddy , et al. July 1, 2 | 2008-07-01 |
Novel Stereoselective Synthesis Of Benzimidazole Sulfoxides App 20080076929 - Reddy; Bandi Parthasaradhi ;   et al. | 2008-03-27 |
Novel Stereoselective Synthesis Of Benzimidazole Sulfoxides App 20080076930 - Reddy; Bandi Parthasaradhi ;   et al. | 2008-03-27 |
Novel processes for preparing sertraline hydrochloride crystalline forms App 20070282129 - Reddy; Bandi Parthasaradhi ;   et al. | 2007-12-06 |
Novel Process For Preparation Of Substituted Sulfoxides App 20070129405 - REDDY; Bandi Parthasaradhi ;   et al. | 2007-06-07 |
Novel process for preparation of valsartan App 20060100443 - Parthasaradhi Reddy; Bandi ;   et al. | 2006-05-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.